Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
metyrapone steroid 11-beta-hydroxylase NA Successful target TTD , DGIDB Pituitary Gland[MeSHID:D010902]
Diagnosis[MeSHID:D003933]
Cushing Syndrome[MeSHID:D003480]
Hypothalamic structure[MeSHID:D007031]
Pituitary Diseases[MeSHID:D010900]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pituitary-dependent Cushing's disease[MeSHID:D047748]		 42.43 approved inhibitor
metyrapone cytochrome p450 11b1, mitochondrial small molecule NA drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Diagnosis[MeSHID:D003933]
Cushing Syndrome[MeSHID:D003480]
Hypothalamic structure[MeSHID:D007031]
Pituitary Diseases[MeSHID:D010900]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pituitary-dependent Cushing's disease[MeSHID:D047748]		 42.43 approved,investigational inhibitor
metyrapone steroid 11-beta-hydroxylase NA Successful target TTD , DGIDB Pituitary Gland[MeSHID:D010902]
Diagnosis[MeSHID:D003933]
Cushing Syndrome[MeSHID:D003480]
Hypothalamic structure[MeSHID:D007031]
Pituitary Diseases[MeSHID:D010900]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pituitary-dependent Cushing's disease[MeSHID:D047748]		 42.43 approved unknown
click here to return to the previous page